| The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies J Ozao-Choy, G Ma, J Kao, GX Wang, M Meseck, M Sung, M Schwartz, ... Cancer research 69 (6), 2514-2522, 2009 | 618 | 2009 |
| Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma JK Salama, EE Vokes, SJ Chmura, MT Milano, J Kao, KM Stenson, ... International Journal of Radiation Oncology* Biology* Physics 64 (2), 382-391, 2006 | 292 | 2006 |
| Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial T Kotz, AD Federman, J Kao, L Milman, S Packer, C Lopez-Prieto, ... Archives of Otolaryngology–Head & Neck Surgery 138 (4), 376-382, 2012 | 251 | 2012 |
| Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer RG Stock, J Kao, NN Stone The Journal of urology 165 (2), 436-439, 2001 | 243 | 2001 |
| Targeting immune suppressing myeloid-derived suppressor cells in oncology J Kao, EC Ko, S Eisenstein, AG Sikora, S Fu, S Chen Critical reviews in oncology/hematology 77 (1), 12-19, 2011 | 190 | 2011 |
| Transoral robotic resection and reconstruction for head and neck cancer EM Genden, T Kotz, CCL Tong, C Smith, AG Sikora, MS Teng, SH Packer, ... The Laryngoscope 121 (8), 1668-1674, 2011 | 181 | 2011 |
| Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage J Kao, A Lavaf, MS Teng, D Huang, EM Genden International Journal of Radiation Oncology* Biology* Physics 71 (2), 362-370, 2008 | 141 | 2008 |
| Adjuvant radiotherapy improves overall survival for patients with lymph node‐positive head and neck squamous cell carcinoma A Lavaf, EM Genden, JA Cesaretti, S Packer, J Kao Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 139 | 2008 |
| HPV-induced oropharyngeal cancer, immune response and response to therapy HL Vu, AG Sikora, S Fu, J Kao Cancer letters 288 (2), 149-155, 2010 | 125 | 2010 |
| Postimplant dosimetry for 125I prostate implants: definitions and factors affecting outcome RG Stock, NN Stone, YC Lo, N Malhado, J Kao, JK DeWyngaert International Journal of Radiation Oncology* Biology* Physics 48 (3), 899-906, 2000 | 124 | 2000 |
| Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis JC Hong, DN Ayala-Peacock, J Lee, AW Blackstock, P Okunieff, MW Sung, ... PloS one 13 (4), e0195149, 2018 | 117 | 2018 |
| The diagnostic and prognostic utility of positron emission tomography/computed tomography‐based follow‐up after radiotherapy for head and neck cancer J Kao, HL Vu, EM Genden, B Mocherla, EE Park, S Packer, PM Som, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 112 | 2009 |
| Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy HM Chen, G Ma, N Gildener-Leapman, S Eisenstein, BA Coakley, J Ozao, ... Clinical Cancer Research 21 (18), 4073-4085, 2015 | 108 | 2015 |
| Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer F Parikh, D Duluc, N Imai, A Clark, K Misiukiewicz, M Bonomi, V Gupta, ... Cancer research 74 (24), 7205-7216, 2014 | 108 | 2014 |
| γ-H2AX as a therapeutic target for improving the efficacy of radiation therapy J Kao, MT Milano, A Javaheri, MC Garofalo, SJ Chmura, ... Current cancer drug targets 6 (3), 197-205, 2006 | 108 | 2006 |
| Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review J Kao, MC Garofalo, MT Milano, SJ Chmura, JR Citron, DJ Haraf Cancer treatment reviews 29 (1), 21-30, 2003 | 106 | 2003 |
| Phase 1 study of concurrent sunitinib and image‐guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response J Kao, S Packer, HL Vu, ME Schwartz, MW Sung, RG Stock, YC Lo, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 100 | 2009 |
| Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial J Kao, CT Chen, CCL Tong, SH Packer, M Schwartz, S Chen, MW Sung Targeted oncology 9, 145-153, 2014 | 91 | 2014 |
| Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer CCL Tong, J Kao, AG Sikora Immunologic research 54, 266-274, 2012 | 85 | 2012 |
| Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases CCL Tong, EC Ko, MW Sung, JA Cesaretti, RG Stock, SH Packer, ... PloS one 7 (6), e36979, 2012 | 79 | 2012 |
